《抗疟药物使用规范》的解读

发布时间：2018-11-21 10:26

【摘要】：本文介绍了《抗疟药物使用规范》的制订和实施对我国疟疾患者个体生命健康和国家公共卫生安全的重要意义。本文在《抗疟药物使用规范》制订过程中,对如何以世界卫生组织相关的文件为指南,结合我国抗疟药物生产和供应的实际情况,以及我国在长期疟疾防治过程中积累的经验,并根据我国消除疟疾进程中的实际需求选择抗疟药物进行了说明。还对新制定的《抗疟药物使用规范》与世界卫生组织《疟疾治疗指南》第3版和原《抗疟药使用原则和用药方案》中抗疟药物使用剂量和疗程的差异进行了较为详细的描述,并对特殊情况下调整抗疟药物的剂量和疗程作了具体的解释,以便于临床医生和公卫医生在临床疟疾患者救治和消除疟疾进程中传染源控制时科学、合理、规范地使用抗疟药物。
[Abstract]:This paper introduces the significance of the formulation and implementation of the guidelines for the use of antimalarial drugs to the individual life and health of malaria patients in China and the national public health safety. In the course of the formulation of the guidelines for the use of antimalarial drugs, this paper discusses how to use the relevant documents of the World Health Organization as a guide, combining with the actual situation of the production and supply of antimalarial drugs in China, as well as the experience accumulated in the long term malaria control process in China. The selection of antimalarial drugs according to the actual demand in the process of eliminating malaria in China was explained. The differences in dosage and course of use of antimalarial drugs between the newly developed guidelines for the use of antimalarial drugs and the World Health Organization guidelines for the treatment of Malaria, the third edition of the guidelines for the treatment of Malaria, and the original principles and programmes for the use of antimalarial drugs are also described in more detail. The specific explanation was given to adjust the dosage and course of antimalarial drugs under special circumstances so as to make it scientific and reasonable for clinicians and public health doctors to control the source of infection in the course of treatment and elimination of malaria in clinical malaria patients. Standard use of antimalarial drugs.
【作者单位】：江苏省血吸虫病防治研究所卫生部寄生虫病预防与控制技术重点实验室;
【分类号】：R978.6

【相似文献】